Drug Topics August 2, 2023
An mHealth app for early detection of skin cancers was followed by an increase in the number of claims for premalignancies.
As the use of artificial intelligence expands across the medical spectrum, researchers sought to determine the effect of a mobile phone app (mHealth) for identifying suspicious skin lesions on healthcare systems. Study authors found that use of an mHealth app for early detection of skin cancers was followed by an increase in the number of claims for premalignancies when matched with a control group.1
In 2019, more than 2.2 million customers of a large Dutch insurance company were invited to use the mHealth (SkinVision) app free of charge. All insureds >18 who completed at least 1 app-based skin assessment...
Today's Sponsors
Today's Sponsor